{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "22768420",
  "DateCompleted": {
    "Year": "2012",
    "Month": "07",
    "Day": "19"
  },
  "DateRevised": {
    "Year": "2012",
    "Month": "07",
    "Day": "06"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0033-2240",
      "JournalIssue": {
        "Volume": "69",
        "Issue": "2",
        "PubDate": {
          "Year": "2012"
        }
      },
      "Title": "Przeglad lekarski",
      "ISOAbbreviation": "Przegl Lek"
    },
    "ArticleTitle": "The management of cancer patients with heart disease.",
    "Pagination": {
      "StartPage": "82",
      "EndPage": "86",
      "MedlinePgn": "82-6"
    },
    "Abstract": {
      "AbstractText": [
        "Cardiovascular disease and cancer are the two leading causes of death in the world, therefore a patient may have cancer, but also heart disease. Intensive cancer treatment, including chemotherapy and radiotherapy, improves the prognosis, reduces mortality and lengthens patients' lives but it is also associated with cardiotoxicity. This paper describes cardiovascular risk factors and methods for the estimation of individual risk before initiation of oncology treatment in subjects at high baseline risk of heart disease. We also describe the way of monitoring patients receiving potentially cardiotoxic treatment and the management of congestive heart failure, coronary artery disease and hypertension in these subjects."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "I Klinika Kardiologii i Nadci\u015bnienia Tetniczego, Instytutu Kardiologii, Uniwersytet Jagiello\u0144ski, Collegium Medicum, Krak\u00f3w."
          }
        ],
        "LastName": "Kawecka-Jaszcz",
        "ForeName": "Kalina",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Bednarek",
        "ForeName": "Agnieszka",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Poland",
    "MedlineTA": "Przegl Lek",
    "NlmUniqueID": "19840720R",
    "ISSNLinking": "0033-2240"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Chemoradiotherapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Monitoring"
    },
    {
      "QualifierName": [
        "etiology",
        "therapy"
      ],
      "DescriptorName": "Heart Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "complications",
        "therapy"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Patient Care Team"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    }
  ]
}